Effect of cardiac resynchronization therapy on reverse remodeling and relation to outcome: multicenter automatic defibrillator implantation trial: cardiac resynchronization therapy
- PMID: 20733097
- DOI: 10.1161/CIRCULATIONAHA.110.955039
Effect of cardiac resynchronization therapy on reverse remodeling and relation to outcome: multicenter automatic defibrillator implantation trial: cardiac resynchronization therapy
Abstract
Background: Cardiac resynchronization therapy (CRT) plus implantation of an implantable cardioverter defibrillator (ICD) reduced the risk of death or heart failure event in patients with mildly symptomatic heart failure, left ventricular dysfunction, and wide QRS complex compared with an ICD only. We assessed echocardiographic changes in patients enrolled in the MADIT-CRT trial (Multicenter Automatic Defibrillator Implantation Trial: Cardiac Resynchronization Therapy) to evaluate whether the improvement in outcomes with CRT plus an ICD was associated with favorable alterations in cardiac size and function.
Methods and results: A total of 1,820 patients were randomly assigned to CRT plus an ICD or to an ICD only in a 3:2 ratio. Echocardiographic studies were obtained at baseline and 12 months later in 1,372 patients. We compared changes in cardiac size and performance between treatment groups and assessed the relationship between these changes over the first year, as well as subsequent outcomes. Compared with the ICD-only group, the CRT-plus-ICD group had greater improvement in left ventricular end-diastolic volume index (-26.2 versus -7.4 mL/m(2)), left ventricular end-systolic volume index (-28.7 versus -9.1 mL/m(2)), left ventricular ejection fraction (11% versus 3%), left atrial volume index (-11.9 versus -4.7 mL/m(2)), and right ventricular fractional area change (8% versus 5%; P<0.001 for all). Improvement in end-diastolic volume at 1 year was predictive of subsequent death or heart failure, with adjustment for baseline covariates and treatment group; each 10% decrease in end-diastolic volume was associated with a 40% reduction in risk (P<0.001).
Conclusions: CRT resulted in significant improvement in cardiac size and performance compared with an ICD-only strategy in patients with mildly symptomatic heart failure. Improvement in these measures accounted for the outcomes benefit. Clinical Trial Registration Information- URL: http://www.clinicaltrials.gov. Unique identifier: NCT00180271.
Similar articles
-
Left ventricular ejection fraction normalization in cardiac resynchronization therapy and risk of ventricular arrhythmias and clinical outcomes: results from the Multicenter Automatic Defibrillator Implantation Trial With Cardiac Resynchronization Therapy (MADIT-CRT) trial.Circulation. 2014 Dec 23;130(25):2278-86. doi: 10.1161/CIRCULATIONAHA.114.011283. Epub 2014 Oct 9. Circulation. 2014. PMID: 25301831 Clinical Trial.
-
Effectiveness of Cardiac Resynchronization Therapy by QRS Morphology in the Multicenter Automatic Defibrillator Implantation Trial-Cardiac Resynchronization Therapy (MADIT-CRT).Circulation. 2011 Mar 15;123(10):1061-72. doi: 10.1161/CIRCULATIONAHA.110.960898. Epub 2011 Feb 28. Circulation. 2011. PMID: 21357819 Clinical Trial.
-
Predictors of response to cardiac resynchronization therapy in the Multicenter Automatic Defibrillator Implantation Trial with Cardiac Resynchronization Therapy (MADIT-CRT).Circulation. 2011 Oct 4;124(14):1527-36. doi: 10.1161/CIRCULATIONAHA.110.014324. Epub 2011 Sep 6. Circulation. 2011. PMID: 21900084 Clinical Trial.
-
[Cardiac resynchronization therapy in terminal heart failure: current status and prospects].Herz. 2001 Feb;26(1):84-8. doi: 10.1007/pl00002010. Herz. 2001. PMID: 11258115 Review. German.
-
Lessons learned from the Multicenter Automatic Defibrillator Implantation Trial-Cardiac Resynchronization Therapy (MADIT-CRT).Trends Cardiovasc Med. 2016 Feb;26(2):137-46. doi: 10.1016/j.tcm.2015.04.013. Epub 2015 Apr 30. Trends Cardiovasc Med. 2016. PMID: 26051208 Review.
Cited by
-
Efficacy of implantable cardioconverter defibrillator or cardiac resynchronization therapy compared with combined therapy in survival of patients with heart failure: a meta-analysis.Medicine (Baltimore). 2015 Feb;94(5):e418. doi: 10.1097/MD.0000000000000418. Medicine (Baltimore). 2015. PMID: 25654375 Free PMC article.
-
Risk factors for the first and second inappropriate implantable cardioverter-defibrillator therapy.Int J Cardiol Heart Vasc. 2021 Apr 26;34:100779. doi: 10.1016/j.ijcha.2021.100779. eCollection 2021 Jun. Int J Cardiol Heart Vasc. 2021. PMID: 33997254 Free PMC article.
-
The efficacy and safety outcomes of cardiac resynchronization therapy in patients with heart failure in Thailand: Phramongkutklao experience.J Arrhythm. 2021 Dec 19;38(1):126-136. doi: 10.1002/joa3.12667. eCollection 2022 Feb. J Arrhythm. 2021. PMID: 35222759 Free PMC article.
-
Right ventricular dysfunction is a predictor of non-response and clinical outcome following cardiac resynchronization therapy.J Cardiovasc Magn Reson. 2011 Oct 31;13(1):68. doi: 10.1186/1532-429X-13-68. J Cardiovasc Magn Reson. 2011. PMID: 22040270 Free PMC article.
-
Left ventricular diameter and risk stratification for sudden cardiac death.J Am Heart Assoc. 2014 Sep 16;3(5):e001193. doi: 10.1161/JAHA.114.001193. J Am Heart Assoc. 2014. PMID: 25227407 Free PMC article.
Publication types
MeSH terms
Associated data
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
Research Materials